Literature DB >> 12117671

Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis.

A Crilly1, J Hamilton, C J Clark, A Jardine, R Madhok.   

Abstract

OBJECTIVES: To determine the distribution of transforming growth factor beta1 (TGFbeta1) genotypes at codon 10 (+869 polymorphism) and codon 25 (+915 polymorphism) in patients with scleroderma (SSc). Differences between diffuse and limited SSc (dSSc and lSSc) were also investigated.
METHODS: Patients with lSSc (n=89) and dSSc (n=63) were compared with 147 controls. DNA was isolated from peripheral blood and polymorphisms at codons 10 (C/T) and 25 (G/C) of the TGFbeta1 gene analysed by polymerase chain reaction and sequence specific oligonucleotide probing.
RESULTS: Significantly more patients with SSc than controls carried allele C at codon 10 (controls v SSc, 38% v 48%, chi(2)=8.2, 1df, p=0.004), OR=1.95 (95% CI 1.16 to 3.27). The difference remained when patients with SSc were split into those with limited or diffuse disease, (controls v dSSc, chi(2)=5, 1df, p=0.02 and controls v lSSc, chi(2)=6, 1df, p=0.013). The patients with SSc had significantly more subjects heterozygous at codon 10 (controls v SSc, chi(2)=45, 1df, p<0.0001). Possession of allele C at codon 10 gave an OR=4.8 (95% CI 2.8 to 8.4). No difference in allele frequency was seen between patients with SSc and controls at codon 25. More patients with SSc than controls carried the GG genotype (controls v SSc, 80% v 88%, chi(2)=7, 2df, p=0.027). Possession of allele G gave an OR=1.7 (95% CI 0.5 to 5.9). There was no difference between diffuse and limited disease at either codon.
CONCLUSIONS: These results suggest that patients with SSc are genetically predisposed to high TGFbeta1 production. These polymorphisms do not, however, explain the difference in the clinical phenotypes of limited and diffuse SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117671      PMCID: PMC1754186          DOI: 10.1136/ard.61.8.678

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Transforming growth factor-beta1 gene polymorphism and bone mineral density.

Authors:  Y Yamada; F Ando; N Niino; H Shimokata
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

3.  Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblasts.

Authors:  J S Perlish; R I Bashey; R E Stephens; R Fleischmajer
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

4.  Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

Authors:  J Uitto; E A Bauer; A Z Eisen
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

5.  Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.

Authors:  L L McCormick; Y Zhang; E Tootell; A C Gilliam
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

6.  Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.

Authors:  X Zhou; F K Tan; D N Stivers; F C Arnett
Journal:  Arthritis Rheum       Date:  2000-05

7.  Severe organ involvement in systemic sclerosis with diffuse scleroderma.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  2000-11

8.  Genetic control of the circulating concentration of transforming growth factor type beta1.

Authors:  D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

9.  Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.

Authors:  J J Avila; P A Lympany; P Pantelidis; K I Welsh; C M Black; R M du Bois
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

10.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  16 in total

1.  A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Authors:  J P Pandey; E C LeRoy
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

3.  Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women.

Authors:  Eun Youn Roh; Jong Hyun Yoon; Eun Young Song; Jin Ju Kim; Kyu Ri Hwang; Soo Hyun Seo; Sue Shin
Journal:  J Assist Reprod Genet       Date:  2016-10-29       Impact factor: 3.412

Review 4.  [Scleroderma associated autoantibodies - clinical and diagnostic relevance].

Authors:  R Mierau; E Genth
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 5.  Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts.

Authors:  Sanjiv J Shah
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

6.  HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

Authors:  Xiaodong Zhou; Jong Eun Lee; Frank C Arnett; Momiao Xiong; Min Young Park; Yeon Kyeong Yoo; Eun Soon Shin; John D Reveille; Maureen D Mayes; Jin Hyun Kim; Ran Song; Ji Yong Choi; Ji Ah Park; Yun Jong Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Rheum       Date:  2009-12

7.  Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.

Authors:  Olivera Tarabar; Bojana Cikota-Aleksić; Ljiljana Tukić; Nenad Milanović; Aleksandar Aleksić; Zvonko Magić
Journal:  Int J Clin Oncol       Date:  2013-03-27       Impact factor: 3.402

Review 8.  The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.

Authors:  Ya-nan Wan; Yu-jie Wang; Jun-wei Yan; Xiang-pei Li; Jin-hui Tao; Bing-xiang Wang; Wen-jia Peng; Jing Wang
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

Review 9.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

10.  Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease.

Authors:  L Wu; J Chau; R P Young; V Pokorny; G D Mills; R Hopkins; L McLean; P N Black
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.